Rp-cAMPS
Based on 7 publication(s) in Google Scholar
Rp-cAMPS, a cAMP analog, is a potent, competitive cAMP-induced activation of cAMP-dependent PKA I and II (Kis of 12.5 µM and 4.5 µM, respectively) antagonist. Rp-cAMPS is resistant to hydrolysis by phosphodiesterases.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 73208-40-9
- Formule: C10H12N5O5PS
- Masse moléculaire:345.27
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
-
HY-12306
8-Bromo-cAMP sodium saltPKA Activator -
HY-103322
6-Bnz-cAMP sodium saltPKA Activator -
HY-12306A
8-Bromo-cAMPPKA Activator -
HY-100530
Rp-cAMPS triethylammonium saltPKA I/II Antagonist -
HY-111673
8-CPT-Cyclic AMP sodiumPKA Activator -
HY-113469A
Cyclic GMP sodiumSecond Messenger -
HY-B0764
Bucladesine sodiumcAMP Analog -
HY-120994B
Sp-8-CPT-cAMPSPKA Activator -
HY-N6789
KT5720PKA Inhibitor -
HY-107543
8-pCPT-2′-O-Me-cAMP sodiumEpac Activator -
HY-100530D
Rp-cAMPS sodium saltPKA I/II Antagonist -
HY-101379A
8-Bromo-cGMP sodiumPKG Activator
Publications Citing Use of MedChemExpress (MCE) Rp-cAMPS
More- Nat Commun. 2025 Jul 1;16(1):5425. [Abstract]
- Redox Biol. 2026 Jun 13:95:104259. [Abstract]
- Theranostics. 2021 Mar 24;11(12):5650-5674. [Abstract]
- Cell Commun Signal. 2024 Jun 3;22(1):307. [Abstract]
- Vanderbilt University. 2026.
- bioRxiv. 2026 Feb 18:2026.02.17.706274. [Abstract]
- Research Square Preprint. 2024 Apr 9.
Activité biologique
Description
IC50 & Target
Ki: 6.05 µM (PKA I) and 9.75 µM (PKA II)[1]
In Vitro
A membrane-permeable competitive cAMP antagonist (Rp-cAMPS) that blocks PKA activation by binding to the regulatory subunits without dissociating the kinase holoenzyme also inhibits synaptic plasticity but has no effect on normal synaptic transmission[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 73208-40-9
-
Masse moléculaire 345.27
-
Formule C10H12N5O5PS
-
SMILES
O[C@H]1[C@@H](O[C@@]2([H])[C@@]1([H])O[P@@](OC2)(S)=O)N3C4=C(C(N)=NC=N4)N=C3
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (7)
-
Journal Impact Factor
-
Most Recent
-
Nat Commun
Protein kinase A is a dependent factor and therapeutic target in mouse models of fibrous dysplasia. [Abstract]2025 Jul 1;16(1):5425. PMID: 40593719 -
Redox Biol
CL-316243 facilitates stable atherosclerotic plaque phenotypes in association with suppression of perivascular adipose tissue ferroptosis via upregulating C/EBPβ. [Abstract]2026 Jun 13:95:104259. PMID: 42289168 -
Theranostics
Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma. [Abstract]2021 Mar 24;11(12):5650-5674. PMID: 33897873 -
Cell Commun Signal
Interleukin-22 receptor 1-mediated stimulation of T-type Ca2+ channels enhances sensory neuronal excitability through the tyrosine-protein kinase Lyn-dependent PKA pathway. [Abstract]2024 Jun 3;22(1):307. PMID: 38831315 -
-
bioRxiv
Regulation of spontaneous neurotransmission and homeostatic synaptic plasticity by synaptotagmin-1 disease variants at the SNARE primary interface. [Abstract]2026 Feb 18:2026.02.17.706274. PMID: 41756855 -
Pureté et documentation
Références
[1]. R J de Wit, et al. Inhibitory action of certain cyclophosphate derivatives of cAMP on cAMP-dependent protein kinases. Eur J Biochem. 1984 Jul 16;142(2):255-60. [Content Brief]
[2]. Rothermel JD, et al. A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3',5'-(cyclic)phosphorothioate with purified cyclic AMP-dependent protein kinase. Biochem J. 1988 May 1;251(3):757-62. [Content Brief]
[3]. Fu Y, et al. PKA and ERK, but not PKC, in the amygdala contribute to pain-related synaptic plasticity and behavior. Mol Pain. 2008 Jul 16;4:26. [Content Brief]
[4]. Kuriyama S, et al. Isoproterenol inhibits rod outer segment phagocytosis by both cAMP-dependent and independent pathways. Invest Ophthalmol Vis Sci. 1995 Mar;36(3):730-6. [Content Brief]
[5]. Dostmann WR, et al. Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3',5'-cyclic phosphorothioates. J Biol Chem. 1990 Jun 25;265(18):10484-91. [Content Brief]
[6]. Van Haastert PJ, et al. Competitive cAMP antagonists for cAMP-receptor proteins. J Biol Chem. 1984 Aug 25;259(16):10020-4. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Rp-cAMPS Related Classifications
HY-100530A Related Classifications
Powered by Bioz